Mapping binding sites of antagonists into the human V1a vasopressin receptor: docking of ligands in the transmembrane binding packet.

被引:0
|
作者
Cotte, N
Balestre, MN
Mahe, E
Phalipou, S
Morin, D
Barberis, C
Hibert, M
Mouillac, B
机构
[1] INSERM U469, F-34094 Montpellier, France
[2] Fac Pharm Strasbourg, F-67401 Illkirch Graffenstaden, France
来源
FASEB JOURNAL | 1999年 / 13卷 / 07期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:A1469 / A1469
页数:1
相关论文
共 50 条
  • [21] CHARACTERIZATION OF SPECIFIC V1A VASOPRESSIN-BINDING SITES ON A RAT MAMMARY-TUMOR-CELL LINE
    GUILLON, G
    KIRK, CJ
    BALESTRE, MN
    BIOCHEMICAL JOURNAL, 1986, 240 (01) : 189 - 196
  • [22] Vasopressin (V1a) receptor binding, mRNA expression and transcriptional regulation by androgen in the Syrian hamster brain
    Young, LJ
    Wang, Z
    Cooper, TT
    Albers, HE
    JOURNAL OF NEUROENDOCRINOLOGY, 2000, 12 (12) : 1179 - 1185
  • [23] Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist -: Comparison with the human V1a vasopressin receptor
    Breton, C
    Chellil, H
    Kabbaj-Benmansour, M
    Carnazzi, E
    Seyer, R
    Phalipou, S
    Morin, D
    Durroux, T
    Zingg, H
    Barberis, C
    Mouillac, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) : 26931 - 26941
  • [24] Critical role of a subdomain of the N-terminus of the V1a vasopressin receptor for binding agonists but not antagonists;: Functional rescue by the oxytocin receptor N-terminus
    Hawtin, SR
    Wesley, VJ
    Parslow, RA
    Patel, S
    Wheatley, M
    BIOCHEMISTRY, 2000, 39 (44) : 13524 - 13533
  • [25] Are there sex differences in oxytocin and vasopressin V1a receptors ligand binding affinities?
    Taylor, Jack H.
    Albers, H. Elliott
    PHARMACOLOGICAL REPORTS, 2024, 76 (02) : 416 - 423
  • [26] Are there sex differences in oxytocin and vasopressin V1a receptors ligand binding affinities?
    Jack H. Taylor
    H. Elliott Albers
    Pharmacological Reports, 2024, 76 : 416 - 423
  • [27] FLUORESCENT AND BIOTINYLATED LINEAR PEPTIDES AS SELECTIVE BIFUNCTIONAL LIGANDS FOR THE V1A VASOPRESSIN RECEPTOR
    HOWL, J
    WANG, XG
    KIRK, CJ
    WHEATLEY, M
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 213 (02): : 711 - 719
  • [28] Synthesis and characterization of fluorescent antagonists and agonists for human oxytocin and vasopressin V1a receptors
    Terrillon, S
    Cheng, LL
    Stoev, S
    Mouillac, B
    Barberis, C
    Manning, M
    Durroux, T
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (12) : 2579 - 2588
  • [29] NOVEL-APPROACH TO THE DESIGN OF SYNTHETIC RADIOIODINATED LINEAR V1A RECEPTOR ANTAGONISTS OF VASOPRESSIN
    MANNING, M
    BANKOWSKI, K
    BARBERIS, C
    JARD, S
    ELANDS, J
    CHAN, WY
    INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, 1992, 40 (3-4): : 261 - 267
  • [30] Synthesis and evaluation of potent and selective human V1a receptor antagonists as potential ligands for PET or SPECT imaging
    Fabio, Karine
    Guillon, Christophe
    Lacey, Carl J.
    Lu, Shi-fang
    Heindel, Ned D.
    Ferris, Craig F.
    Placzek, Michael
    Jones, Graham
    Brownstein, Michael J.
    Simon, Neal G.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (03) : 1337 - 1345